By Cynthia Chmielewski | Posted - Nov 12th, 2021





HealthTree University: Specific Myeloma Genetics Mutations and Risk (1/3)

Did you know that the genetics of your myeloma affect how high-risk or low-risk your disease is? Some of the top myeloma doctors in the world answered our questions about risk, genetics and even treatment of the different cytogenetic abnormalities that crop up in multiple myeloma. You can watch the following HealthTree University videos to learn more about this important aspect of your disease. You can watch the entire course at

20.01    How does genetic testing help assess risk? Why is knowing risk stratification important?


20.02    What is the definition of high-risk Multiple Myeloma (HRMM)


20.03    What chromosomal abnormalities are considered high-risk, standard risk?


20.04    What is meant by hyperdiploid myeloma? How does this affect risk?


20.05    What is a 1q gain? How does this affect risk of progression?


We’d like to thank our faculty who donated their time in creating these videos, including:

  • Rafael Fonseca, MD
  • Craig Hofmeister, MD, MPH
  • Cesar Rodriguez Valdes, MD
  • Brian Van Ness, PhD
  • Martin Kaiser, MD

Want more?

We have over 300 HealthTree University videos online at! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!


Cynthia Chmielewski
About the Author

Cynthia Chmielewski - Cynthia Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University.


Add a Comment



Thanks to our Myeloma Crowd Community sponsors:

.                         .       .